June 16, 2016
San Diego medical device companies received the most venture capital investment since 2009, a new CBRE Q1 2016 Capital Recap found. While investment was down compared to 2015 numbers, it is roughly on par with the quarterly average from 2013 to 2015.
Overall trends reveal that total VC investments in San Diego firms declined 28% in Q1 to $253.5 million from Q4 2015, and 32.1% from Q1 2015. Deal volume was also down to 21, the fewest since Q2 2013.
Other highlights include from the Life Science sector:
- Medical device investments led all industry types in Q1 with $95 million in VC investment, the most since Q2 2009.
- San Diego represented 18.7% of all medical device deals in the US in Q1.
- Two of the largest med device deals in the US in Q1 2016 were to San Diego regional companies. Carlsbad’s Acutus Medical ($75 million) and San Diego’s BioTheranostics ($30 million).
- An unusually low volume of biotech deals (6) were done in Q1, with dollar volume reaching only $85 million.
- This is 65% lower than the quarterly average over 2013 to 2015, which is typically around $140 million.